These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 37578983)

  • 1. The ubiquitin-like modifier FAT10 covalently modifies HUWE1 and strengthens the interaction of AMBRA1 and HUWE1.
    Mueller S; Bialas J; Ryu S; Catone N; Aichem A
    PLoS One; 2023; 18(8):e0290002. PubMed ID: 37578983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conjugation of the ubiquitin activating enzyme UBE1 with the ubiquitin-like modifier FAT10 targets it for proteasomal degradation.
    Bialas J; Groettrup M; Aichem A
    PLoS One; 2015; 10(3):e0120329. PubMed ID: 25768649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigations into the auto-FAT10ylation of the bispecific E2 conjugating enzyme UBA6-specific E2 enzyme 1.
    Aichem A; Catone N; Groettrup M
    FEBS J; 2014 Apr; 281(7):1848-59. PubMed ID: 24528925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. USE1 is a bispecific conjugating enzyme for ubiquitin and FAT10, which FAT10ylates itself in cis.
    Aichem A; Pelzer C; Lukasiak S; Kalveram B; Sheppard PW; Rani N; Schmidtke G; Groettrup M
    Nat Commun; 2010 May; 1():13. PubMed ID: 20975683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor necrosis factor mediates USE1-independent FAT10ylation under inflammatory conditions.
    Schnell L; Zubrod A; Catone N; Bialas J; Aichem A
    Life Sci Alliance; 2023 Nov; 6(11):. PubMed ID: 37604583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Parkin is an E3 ligase for the ubiquitin-like modifier FAT10, which inhibits Parkin activation and mitophagy.
    Roverato ND; Sailer C; Catone N; Aichem A; Stengel F; Groettrup M
    Cell Rep; 2021 Mar; 34(11):108857. PubMed ID: 33730565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LMO2 blocks the UBA6-USE1 interaction and downstream FAT10ylation by targeting the ubiquitin fold domain of UBA6.
    Wu C; Liu Y; Gu X; Zhu T; Yang S; Sun W
    Biochem Biophys Res Commun; 2016 Sep; 478(3):1442-8. PubMed ID: 27569286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FAT10 : Activated by UBA6 and Functioning in Protein Degradation.
    Pelzer C; Groettrup M
    Subcell Biochem; 2010; 54():238-46. PubMed ID: 21222287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The FAT10 post-translational modification is involved in the lytic replication of Kaposi's sarcoma-associated herpesvirus.
    Sugimoto A; Abe Y; Watanabe T; Hosokawa K; Adachi J; Tomonaga T; Iwatani Y; Murata T; Fujimuro M
    J Virol; 2021 Apr; 95(10):. PubMed ID: 33627385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The ubiquitin-like modifier FAT10 stimulates the activity of deubiquitylating enzyme OTUB1.
    Bialas J; Boehm AN; Catone N; Aichem A; Groettrup M
    J Biol Chem; 2019 Mar; 294(12):4315-4330. PubMed ID: 30718280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The proteomic analysis of endogenous FAT10 substrates identifies p62/SQSTM1 as a substrate of FAT10ylation.
    Aichem A; Kalveram B; Spinnenhirn V; Kluge K; Catone N; Johansen T; Groettrup M
    J Cell Sci; 2012 Oct; 125(Pt 19):4576-85. PubMed ID: 22797925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The structure of the ubiquitin-like modifier FAT10 reveals an alternative targeting mechanism for proteasomal degradation.
    Aichem A; Anders S; Catone N; Rößler P; Stotz S; Berg A; Schwab R; Scheuermann S; Bialas J; Schütz-Stoffregen MC; Schmidtke G; Peter C; Groettrup M; Wiesner S
    Nat Commun; 2018 Aug; 9(1):3321. PubMed ID: 30127417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. UBA6 and Its Bispecific Pathways for Ubiquitin and FAT10.
    Wang F; Zhao B
    Int J Mol Sci; 2019 May; 20(9):. PubMed ID: 31067743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of modification and proteolytic targeting by the ubiquitin-like modifier FAT10.
    Aichem A; Boehm AN; Catone N; Schmidtke G; Groettrup M
    Methods Enzymol; 2019; 618():229-256. PubMed ID: 30850054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanistic studies on activation of ubiquitin and di-ubiquitin-like protein, FAT10, by ubiquitin-like modifier activating enzyme 6, Uba6.
    Gavin JM; Chen JJ; Liao H; Rollins N; Yang X; Xu Q; Ma J; Loke HK; Lingaraj T; Brownell JE; Mallender WD; Gould AE; Amidon BS; Dick LR
    J Biol Chem; 2012 May; 287(19):15512-22. PubMed ID: 22427669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FAT10ylation as a signal for proteasomal degradation.
    Schmidtke G; Aichem A; Groettrup M
    Biochim Biophys Acta; 2014 Jan; 1843(1):97-102. PubMed ID: 23333871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structures of UBA6 explain its dual specificity for ubiquitin and FAT10.
    Truongvan N; Li S; Misra M; Kuhn M; Schindelin H
    Nat Commun; 2022 Aug; 13(1):4789. PubMed ID: 35970836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The ubiquitin-like modifier FAT10 inhibits retinal PDE6 activity and mediates its proteasomal degradation.
    Boehm AN; Bialas J; Catone N; Sacristan-Reviriego A; van der Spuy J; Groettrup M; Aichem A
    J Biol Chem; 2020 Oct; 295(42):14402-14418. PubMed ID: 32817338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FAT10 inhibits TRIM21 to down-regulate antiviral type-I interferon secretion.
    Saxena K; Inholz K; Basler M; Aichem A
    Life Sci Alliance; 2024 Sep; 7(9):. PubMed ID: 38977311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The ubiquitin-like modifier FAT10 interferes with SUMO activation.
    Aichem A; Sailer C; Ryu S; Catone N; Stankovic-Valentin N; Schmidtke G; Melchior F; Stengel F; Groettrup M
    Nat Commun; 2019 Oct; 10(1):4452. PubMed ID: 31575873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.